Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06463834 - No phaseNot yet taking people in ChinaA Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Wuhan University
See details and how to joinNCT06464601 - Phase 2Taking peopleRadiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
- Where
- Beijing
- Age
- 18 years and over
- People
- 120
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06084897 - Phase 2Not yet taking people in ChinaConversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer
- Where
- Tianjin
- Age
- 18 years to 70 years
- People
- 158
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06454435 - Phase 2Taking peopleNeoadjuvant Immunotherapy Plus Chemotherapy in Borrmann Type 4 and Large Type 3 Gastric Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 53
- Run by
- Sun Yat-sen University
See details and how to joinNCT06451211 - No phaseTaking peoplePredicting Gastric Cancer Response to Chemo With Multimodal AI Model
- Where
- Guangzhou
- Age
- 20 years to 90 years
- People
- 500
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06451393 - Phase 2Taking peopleToripalimab Plus FLOT in Locally Advanced Gastric Cancer
- Where
- Zhengzhou
- Age
- 18 years to 70 years
- People
- 60
- Run by
- Henan Cancer Hospital
See details and how to joinNCT04891016 - Phase 2Taking peopleA Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06415669 - Phase 2Taking peopleNimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 55
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06429839 - No phaseTaking peoplea Single-arm, Single-center, Open Clinical Study
- Where
- Zhengzhou
- Age
- 18 years to 75 years
- People
- 10
- Run by
- Beijing Geekgene Technology Co., LTD
See details and how to joinNCT06431100 - No phaseTaking peopleShort-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
- Where
- Hefei
- Age
- 18 years and over
- People
- 25
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06408584 - No phaseNot yet taking people in ChinaEvaluation of the Efficacy and Safety of Indocyanine Green Tracing in 3D Fluorescent Laparoscopic Lymph Node Dissection for Gastric Cancer
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 484
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06421220 - Phase 4Taking peopleDeeper Intubation Make Effects on Cervical Esophageal ESD
- Where
- Fuzhou
- Age
- 18 years to 80 years
- People
- 40
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT06420258 - No phaseTaking peopleDual-Port Laparoscopic Distal Gastrectomy for Gastric Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT05494086 - Phase 2Taking peopleNimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 53
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06410651 - Phase 2Taking peoplePhase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Peking University
See details and how to joinNCT06023758 - Phase 3Taking peopleLocal Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
- Where
- Shanghai
- Age
- 18 years and over
- People
- 354
- Run by
- Fudan University
See details and how to joinNCT06190782 - Phase 2/3Taking peopleTislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 130
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05699655 - No phaseTaking peopleMulticenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06385717 - Phase 2Not yet taking people in ChinaTislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 134
- Run by
- Xiangdong Cheng
See details and how to joinNCT06374901 - Phase 2Taking peopleNeo-Sequence 2:NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 67
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06371586 - Phase 2Taking peopleSerplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
- Where
- Nanjing
- Age
- 75 years and over
- People
- 50
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06354218 - Phase 2/3Taking peopleA Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Chongqing
- Age
- 18 years to 80 years
- People
- 266
- Run by
- Army Medical Center of PLA
See details and how to joinNCT06354530 - Phase 2/3Taking peopleDV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy
- Where
- Beijing, Changsha, Chengdu, Harbin, Jinan, Kunming, Qingdao, Shanghai, Wuhan, Xiamen, Xuzhou, Zhengzhou
- Age
- 18 years to 75 years
- People
- 90
- Run by
- RemeGen Co., Ltd.
See details and how to joinNCT06221748 - Phase 2Taking peopleConcurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06341595